Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 0.00 |
Average volume | -- |
---|---|
Shares outstanding | 429.67m |
Free float | 429.67m |
P/E (TTM) | -- |
Market cap | 719.62m DKK |
EPS (TTM) | -0.163 DKK |
Data delayed at least 20 minutes, as of Apr 22 2024.
More ▼
Announcements
- BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024
- BioPorto offentliggør delårsresultater og opdatering for tredje kvartal og ni måneder af regnskabsåret 2024
- Grant of Warrants
- First Patient In - BioPorto Initiates Patient Enrollment for US Study of ProNephro AKI (NGAL)™ for Adult Use at Massachusetts General Hospital
- Første patient indrulleret - BioPorto har påbegyndt indrullering til det amerikanske studie vedrørende ProNephro AKI (NGAL)™ til voksen brug ved Massachusetts General Hospital
- BioPorto Enters Global Distribution Partnership with Beckman Coulter for Acute Kidney Injury NGAL Tests
- BioPorto indgår globalt distributionspartnerskab med Beckman Coulter om NGAL Tests til akut nyreskade
- BioPorto Announces Interim Results and Business Update for the Second Quarter and Six Months of Fiscal 2024
- Managers’ transactions
- Changes of number of shares and votes in BioPorto A/S
More ▼